Best Life Sciences Platforms and Tools Companies in Connecticut, United States
The 38 best Life Sciences Platforms and Tools companies in Connecticut, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: IsoPlexis.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Connecticut
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | IsoPlexis Developer of multiplexed single-cell analysis tools for the diagnostics and life science research | $186M | 68 mo ago | Acquired | 195 | — | — | 72 patents Single-cell immune profiling and multiplexed analysis of cellular therapeutics | — |
| 2 | Molecular Staging Transforming detection and measurement of proteins and nucleic acids for life sciences | $50M | 184 mo ago | Deadpooled | — | Torben Spanget Christensen ex-CEO | — | — | — |
| 3 | Ion Torrent Next generation sequencing using semiconductor technology. | $37M | 198 mo ago | Acquired | — | Jonathan Rothberg Founder & CEO | — | — | — |
| 4 | Biological Industries Cell culture media, reagents, and biopreservation solutions for biopharmaceutical research and manufacturing | $11M | 112 mo ago | Acquired | 5 | — | — | — | — |
| 5 | Affomix Video playlist creation and sharing platform with feedback and communication features | $7M | 220 mo ago | Acquired | — | — | — | 20 patents Protein interaction screening and engineered antibody fragment specificity using nucleic‑acid scaffolds | — |
| 6 | ProteoWise Provider of a platform for the analysis of proteomics | $6M | 21 mo ago | Series A | — | Mikhail Kostylev Co-Founder | — | 6 patents Multiplexed microfluidic platforms for simultaneous biomarker capture and analysis | — |
| 7 | AxioMx Operates a recombinant antibody discovery and development services platform | $4M | 135 mo ago | Acquired | 28 | Christopher McLeod Co-Founder & CEO | — | 62 patents Protein engineering platforms for directed evolution and membrane protein binder discovery | — |
| 8 | RNAConnect Provider of reverse transcriptase solutions for RNA analysis | $4M | 17 mo ago | Funding Raised | — | Ryan Muldoon Co-Founder & CEO | Cart FunctionalityShopifyShop Pay+17 | — | — |
| 9 | Potentiometric Probes Developer of voltage-sensitive dyes for biological research | $3M | 17 mo ago | Funding Raised | — | Ping Yan Co-Founder | Cart FunctionalitySquarespace CommerceSquarespace+16 | — | — |
| 10 | Intus Bio Developer of sequencing technology for microbiome testing, pathogen identification, and tracking | $3M | 16 mo ago | Seed | 9 | Ken Beers CEO | — | — | — |
| 11 | Enrich Biosystems Provider of cell therapy development platform services | $2M | 10 mo ago | Series A | 17 | Dong Wang Co-founder | WordPressMySQLPHP+21 | — | — |
| 12 | DIANT Pharma Developer of technology for the synthesis of nanoparticles | $1M | 47 mo ago | Seed | 9 | Diane Burgess Co-Founder | WordPressMySQLPHP+21 | — | — |
| 13 | My Gene Counsel Digital genetic counseling platform bridging genetics and precision medicine | $1M | 100 mo ago | Seed | 25 | — | WordPressMySQLPHP+15 | — | 1 job opening |
| 14 | Onkologic Developer of NK cell culture media for cell therapies | $305K | 52 mo ago | Seed | — | Rachit Ohri Founder & CEO | — | — | — |
| 15 | FMP Products Designs and manufactures Laboratory automation products and accessories. | $300K | 197 mo ago | Deadpooled | — | Rye Brook CEO & President | — | — | — |
| 16 | Propria Developer of technology to produce engineered heart tissues for research and drug discovery | $260K | 54 mo ago | Funding Raised | 38 | — | — | 5 patents In vitro tissue engineering platforms for generating and testing engineered biological tissues. | — |
| 17 | QCDx Developer of instruments for the detection of rare cells in the blood circulation | $130K | 16 mo ago | Seed | 9 | — | — | 23 patents Liquid biopsy diagnostics: detecting circulating tumor cells, viral pathogens, and biomarkers in biological samples. | — |
| 18 | CheminPharma Biotech tools and services: medicinal chemistry, custom synthesis, chemical development | $105K | 156 mo ago | Funding Raised | 4 | — | — | 2 patents Design of heterocyclic small‑molecule ligands that stabilize and regulate protein function. | — |
Top 12 Life Sciences Platforms and Tools companies in Connecticut
#1
Series A · Branford, Connecticut · founded 2022 · 17 employees$2.2Mraised▾
Provider of cell therapy development platform services
- Nov 2025Series A$1.4M
- May 2024Series A$2.2M
- Aug 2022Grant (prize money)$1.7M
- Jun 2022Series A$3.8M
#2
Seed · Farmington, Connecticut · founded 2014 · 9 employees$3.1Mraised▾
Developer of sequencing technology for microbiome testing, pathogen identification, and tracking. It offers a platform, called Titan-1 which ses a patented 16S-ITS-23S amplicon to generate information to differentiate strains without sequencing the whole genome.
- May 2025Seed$1.1M
- Jun 2024Conventional Debt—
- Jun 2024Seed$2M
- Nov 2022Seed$1.1M
#3
Funding Raised · Farmington, Connecticut · founded 2017$3.1Mraised▾
Developer of voltage-sensitive dyes for biological research. These dyes are used by academic and pharmaceutical researchers to visualize electrical activity in cells, tissues, and organs. The company offers a range of classic, fluorinated, and long-wavelength dyes, enabling researchers to study various biological systems and advance drug discovery. Applications include cardiac and neuroscience research, as well as high-throughput screening. The dyes facilitate ratiometric voltage imaging, improving signal quality and reducing artifacts.
- Apr 2025Grant (prize money)$282.3K
- Jan 2024Grant (prize money)$282.3K
- Sep 2023Grant (prize money)$1.9M
- Sep 2019Grant (prize money)$450K
#4
Funding Raised · Branford, Connecticut · founded 2023$4.1Mraised▾
Provider of reverse transcriptase solutions for RNA analysis. It offers UltraMarathonRT a next-generation, ultra-processive reverse transcriptase that creates full-length cDNAs from any RNA template. It is used for discovery of gene expression, cell, gene, and RNA therapy vaccine, and diagnostics.
- Apr 2025Grant (prize money)$2.5M
- May 2024Grant (prize money)$1.6M
#5
Series A · New Haven, Connecticut · founded 2018$6.3Mraised▾
Proteo Wise involvs in the proteomic analysis. The company's patented product 3 Dimensional Nano Scale Protein Capture (3D-NPC) technology is used for protein analysis. In this technology, the nanoscale material binds with the protein and then with antibody probes to give result.
- Dec 2024Series A$2.3M
- Jun 2020Grant (prize money)$251.9K
- Mar 2020Series A$6.3M
#6
Acquired · New Haven, Connecticut · founded 2012 · 195 employees$185.9Mraised▾
Developer of multiplexed single-cell analysis tools for diagnostics and life science research. Their specialties include 'secretome analysis for applications in immune monitoring, vaccine response evaluation, personalized medicine, adoptive immune therapies, stem cell research, and oncology.
- Jan 2021Conventional Debt$50M
- Jan 2021Series D$92.5M
- Jun 2020Grant (prize money)$2M
- Jan 2020Series C$20M
#7
Seed · Farmington, Connecticut · founded 2016 · 9 employees$130Kraised▾
Developer of instruments for the detection of rare cells in the blood circulation. The products of the company include RareScope a Rare Cell Detection, RarePrep holds cells immobilized in the life-sustaining hydrogel, RarePicker, and RareVivo.
- May 2025Conventional Debt$5.3M
- May 2025Seed$1.7M
- Dec 2017Seed$130K
#8
Deadpooled · New Haven, Connecticut · founded 1998$49.5Mraised▾
Transforming detection and measurement of proteins and nucleic acids for life sciences. This is a life sciences company providing enabling technologies for genomics and proteomics data analysis. They offer products and services based on technologies transforming the detection and measurement of both proteins and nucleic acids. Their offerings include high-coverage protein microarrays, whole-genome amplification, and ultra-sensitive, multiplexed diagnostics. The company focuses on developing and commercializing gene-based tests and immunoassays using Rolling Circle Amplification Technology (RCAT™) to improve the diagnosis of cancer, infectious diseases, neuropsychiatric disorders, and autoimmune disorders. They aim to redefine diagnostic accuracy, enabling earlier disease detection and improving patient outcomes.
- Apr 2011Grant (prize money)$640.4K
- Jul 2004Grant (prize money)$640.4K
- 2004Grant (prize money)$2.1M
- 2003Grant (prize money)$99.6K
#9
Acquired · Guilford, Connecticut · founded 2007$37.1Mraised▾
Ion Torrent developed tools for next-generation sequencing using semiconductor technology. It used a proprietary platform that followed a sequencing-by-synthesis approach and sequenced genomes by measuring the release of hydrogen ions as a result of DNA ligation using an ISFET sensor. The company was acquired by Life Technologies for $725M in Aug 2010, which was then acquired by ThermoFisherScientific in 2013.
- Mar 2010Series C$37.1M
#10
Acquired · Cromwell, Connecticut · founded 1982 · 5 employees$11Mraised▾
Cell culture media, reagents, and biopreservation solutions for biopharmaceutical research and manufacturing. The company provides essential tools for cell culture, including classical media, cell culture lab waters and buffers, reagents, and supplements. It offers specialized cell therapy media designed to maximize cell quality and reproducibility. Biopreservation solutions are available for both short-term cold storage and long-term cryopreservation, ensuring the viability of sensitive cells. The company supports research and development in areas like cell therapy, molecular biology, and biopharmaceutical production. The company focuses on delivering high-quality products and services to support advancements in life sciences.
- Apr 2017PE$11M
#11
Seed · Mansfield, Connecticut · founded 2019 · 9 employees$1.4Mraised▾
Developer of technology for the synthesis of nanoparticles. The company's product can be used in the production of liposomes, solid lipid nanoparticles, nucleic acid/lipid complexes, polymeric micelles, and solid suspensions.
- Sep 2022Seed$1.4M
- Feb 2022Grant (prize money)$256K
#12
Acquired · New Haven, Connecticut · founded 2006$7Mraised▾
Video playlist creation and sharing platform with feedback and communication features. This platform enables users to create, share, and manage video playlists. It offers features like chat, feedback mechanisms, email sharing, and options to play videos in full screen. The platform supports playlist customization with options to shuffle, repeat, and clear playlists. It also provides functionalities for user engagement, such as commenting and rating videos. The service focuses on enhancing video content accessibility and sharing, fostering a community around curated video experiences. It is a B2C platform that offers video content management and social sharing capabilities.
- May 2008Grant (prize money)$111.3K
- Jan 2008Series A$7M
- Dec 2007Grant (prize money)$100K
- Nov 2007Grant (prize money)$100K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Connecticut is moving
A read on the academic research around Bioinformatics in Connecticut — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 43 papers.
- University of Connecticut31
- VA Connecticut Healthcare System5
- Connecticut Agricultural Experiment Station3
- Southern Connecticut State University2
- Connecticut Children\'s Medical Center2
- Genome5
- Gene4
- Function (biology)3
- Microbiome2
- Lung1
- Nucleic acid2
- Phylogenetic network1
- Phylogenetic tree1
- Reticulate evolution1
- Phylogenetics1
- Rimonabant1
- Endocannabinoid system1
- Human studies1
- Preclinical research1
- Cannabidiol1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.